Table 1

Summary demographic information and clinical measures by group

VariableControlsIndividuals with ARMSPatients with FEPGroup comparison
nMean ± SDnMean ± SDnMean ± SDStatisticp value
Total no. of participants312326
Age, yr3022.57 ± 3.682321.22 ± 3.402524.56 ± 4.67F2,75 = 4.38*0.016
Genderχ22 = 8.060.018
 Female1463
 Male161722
Antipsychotic medicationχ22 = 43.43< 0.001
 Yes0219
 No29217
Clinical measures
 WASI2730.52 ± 3.391827.56 ± 4.712128.48 ± 5.11F2,63 = 2.77*0.070
 CAARMS intensity and frequency265.46 ± 3.842129.52 ± 6.712433.67 ± 6.23H2 = 51.28§< 0.001
 SPQ298.21 ± 6.342135.43 ± 12.102334.22 ± 19.60H2 = 37.70§< 0.001
 PANSS positiveNANA2116.86 ± 2.782221.27 ± 6.22t29.36 = −3.030.005
 PANSS negativeNANA2114.48 ± 5.952214.82 ± 7.37W = 239.5**0.845
 CAPSNANA2111.62 ± 7.262211.45 ± 9.43W = 235.5**0.922
 PDINANA217.76 (4.39)229.14 (5.69)t39.31 = −0.890.380
 MFQNANA2129.67 (15.04)2431.00 (26.32)W = 269.5**0.699
  • ARMS = at-risk mental state, CAARMS = Comprehensive Assessment of At-Risk Mental States (excluding 2 items on aggression and suicidality), CAPS = Clinician-Administered PTSD Scale, FEP = first-episode psychosis, MFQ = Mood and Feelings Questionnaire, NA = not applicable, PANSS = Positive And Negative Symptoms Scale, PDI = Peters et al. Delusions Inventory, SD = standard deviation, SPQ = Schizotypal Personality Questionnaire, WASI = Wechsler Abbreviated Scale of Intelligence.

  • * Calculated using 1-way analysis of variance.

  • Calculated using the Pearson χ2 test.

  • Scores ranged as follows: CAARMS 0–48, SPQ 0–74, PANSS positive 7–49, PANSS negative 7–49, CAPS 0–32, PDI 0–21, MFQ 0–66.

  • § Calculated using the Kruskal–Wallis test.

  • Calculated using the Welch t test.

  • ** Calculated using the Wilcoxon rank-sum test.